Israel Englander Collegium Pharmaceutical, Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Millennium Management LLC holds 133,946 shares of COLL stock, worth $4.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,946

Previous 303,870 55.92%

Holding current value

$4.11 Million

Previous $9.78 Million 47.11%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $5.34 Million - $6.64 Million	-169,924 Reduced 55.92%	133,946 $5.18 Million
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $3.47 Million - $4.42 Million	110,499 Added 57.14%	303,870 $9.78 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $40.91 $7.82 Million - $10.2 Million	-250,274 Reduced 56.41%	193,371 $7.51 Million
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $2.17 Million - $3.16 Million	102,723 Added 30.13%	443,645 $13.7 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $5.13 Million - $5.84 Million	-243,388 Reduced 41.65%	340,922 $7.33 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $12.5 Million - $16.2 Million	543,729 Added 1339.86%	584,310 $14 Million
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $6.93 Million - $10.1 Million	-429,094 Reduced 91.36%	40,581 $941,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $7.07 Million - $9.2 Million	457,604 Added 3790.94%	469,675 $7.52 Million
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $171,649 - $252,042	12,071 New	12,071 $214,000
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $946,732 - $1.16 Million	-54,099 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $1.43 Million - $2.05 Million	-80,638 Reduced 59.85%	54,099 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $1.28 Million - $1.49 Million	58,847 Added 77.54%	134,737 $3.19 Million
Q1 2021 May 17, 2021	SELL	$19.25 - $26.1 $2.04 Million - $2.76 Million	-105,908 Reduced 58.26%	75,890 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $2.94 Million - $3.67 Million	164,648 Added 960.05%	181,798 $3.64 Million
Q3 2020 Nov 16, 2020	BUY	$15.78 - $20.82 $270,627 - $357,063	17,150 New	17,150 $357,000
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $2.08 Million - $3.81 Million	-149,575 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $1.6 Million - $3.33 Million	149,575 New	149,575 $3.08 Million
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $130,169 - $170,143	-12,812 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$10.62 - $16.59 $354,007 - $553,011	-33,334 Reduced 72.24%	12,812 $168,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $232,493 - $363,188	-21,892 Reduced 32.18%	46,146 $14.5 Million
Q1 2019 May 14, 2019	SELL	$13.58 - $18.72 $16.8 Million - $23.2 Million	-1,236,963 Reduced 94.79%	68,038 $1.03 Million
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $17.3 Million - $23 Million	1,169,537 Added 863.36%	1,305,001 $22.4 Million
Q3 2018 Nov 14, 2018	SELL	$14.16 - $24.3 $3.19 Million - $5.48 Million	-225,571 Reduced 62.48%	135,464 $2 Million
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $7.25 Million - $9.41 Million	332,647 Added 1171.79%	361,035 $8.61 Million
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $686,596 - $1.1 Million	-37,829 Reduced 57.13%	28,388 $725,000
Q4 2017 Feb 14, 2018	SELL	$9.3 - $19.14 $10.3 Million - $21.2 Million	-1,106,580 Reduced 94.35%	66,217 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $10.7 Million - $14 Million	1,172,797	1,172,797 $12.3 Million

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.05B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account